These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 15231375

  • 1. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR, Monraats PS, Zwinderman AH, De Winter RJ, Tio RA, Doevendans PA, Waltenberger J, De Maat MP, Frants RR, Atsma DE, Van Der Laarse A, Van Der Wall EE, Jukema JW.
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [Abstract] [Full Text] [Related]

  • 2. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
    Ahmed WH, Zambahari R, Al-Rashdan I, Al Naeemi A, Saeed FA, Mascioli S.
    J Interv Cardiol; 2008 Dec; 21(6):512-8. PubMed ID: 18973513
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME, TAXUS VI Investigators.
    Circulation; 2005 Nov 22; 112(21):3306-13. PubMed ID: 16286586
    [Abstract] [Full Text] [Related]

  • 4. Use of stents for small coronary arteries. Results of the Multi-Link 2.5 Portuguese Registry.
    Seabra-Gomes R, Farto eAbreu P, Marques AL, Pereira H, da Cunha JA, Carvalho H, Ribeiro VG, Garcia LM, Mourão L, dos Santos LP, Providência L, Figueiredo L, Almeida M, Cavaco D.
    Rev Port Cardiol; 2001 Sep 22; 20(9):819-37. PubMed ID: 11763595
    [Abstract] [Full Text] [Related]

  • 5. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M, Gori T, Pierli C, Casini S, Sinicropi G, Buti A, Del Pasqua A, Bravi A.
    Can J Cardiol; 2005 Dec 22; 21(14):1281-5. PubMed ID: 16341297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB, Xu B, Qiao SB, Yang YJ, Ma WH, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Li JJ, Chen JL, Gao RL.
    Chin Med J (Engl); 2007 Apr 05; 120(7):574-7. PubMed ID: 17442205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W, European Society of Cardiology.
    Eur Heart J; 2005 Jun 05; 26(12):1169-79. PubMed ID: 15802360
    [Abstract] [Full Text] [Related]

  • 11. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 05; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen J, Venema AC, Serruys PW, Bogers AJ.
    Eur Heart J; 2005 Apr 05; 26(7):675-81. PubMed ID: 15637087
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR, Rao A, Asghar O, Ramsdale KA, McKay E.
    J Invasive Cardiol; 2008 Oct 05; 20(10):493-500. PubMed ID: 18829991
    [Abstract] [Full Text] [Related]

  • 18. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R, Hu S.
    Circulation; 2009 Apr 21; 119(15):2040-50. PubMed ID: 19349321
    [Abstract] [Full Text] [Related]

  • 19. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM.
    J Invasive Cardiol; 2006 Sep 21; 18(9):405-8. PubMed ID: 16954577
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):976-83. PubMed ID: 17295334
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.